PHYSICOCHEMICAL CHARACTERIZATION AND HEPATOPROTECTIVE ACTIVITY OF MANDUR BHASMA
Objective: Bhasmas are traditional Indian medicinal preparations that are standardized using quality control tests prescribed by Ayurveda and other guidelines. There is a need to study the adequacy of the existing quality control tests and to correlate these to the performance of the product. No attempt has been made in the literature to study the adequacy of these tests in determining the biological activity of a product and to suggests new analytical techniques for determining the quality. In the present work, an attempt has been made to compare marketed samples of Mandur bhasma with respect to various existing quality control tests and to analyze these samples using modern analytical techniques for the complete analysis of Mandur Bhasma. Adequacy of all the tests and techniques was studied with respect to the hepatoprotective activity of mandur bhasma in paracetamol induced hepatotoxicity in rats.
Methods: The marketed products of three leading brands of Mandur Bhasma were analyzed for quality-control tests as prescribed by Ayurveda and other guidelines. These samples were also analysed using modern analytical techniques like AAS, IR, XRD, HPTLC, SEM. These formulations were then evaluated for their hepatoprotective activity in paracetamol induced hepatotoxicity in rats and the results obtained were correlated with analytical results.
Results: It was found that all the three bhasma samples were passing in quality control tests as prescribed by Ayurveda and other guidelines. These samples produced similar results when analyzed using AAS and IR. The results were different when analyzed using colorimetry, HPTLC, SEM and XRD. The extent of hepatoprotection in rats with paracetamol induced hepatotoxicity was also found to be different in the three samples.
Conclusion: The analysis was carried out on three different marketed samples, and a correlation has been reported. It was seen that although all the three formulations passed traditional quality control tests and the tests laid by regulatory guidelines, but still there were significant differences in their biological activity. Analysis of iron content using colorimetric method was found to be discriminating in estimating the biologically effective form of iron. It was also found that HPTLC, XRD and SEM should be further developed and validated as analytical tools in determining the quality of Mandur bhasma product.
Keywords: Mandur bhasma, Colorimetry, IR, AAS, SEM, XRD, HPTLC, Hepatoprotective activity
2. Pal D, Sahu CK, Haldar A. Bhasma: the ancient Indian nanomedicine. J Adv Pharm Technol Res 2014;5:4-12.
3. Kulkarni-Dudhgaonkar SB. Rasaratna Samuchyaya. Kolhapur: Shivaji University Publication; 1970. p. 158.
4. Patel NG. Ayurveda: The traditional medicine of India. In: Steiner RP. editor. Folk Medicine: the Art and the Science. Washington DC: American Chemical Society, USA; 1986. p. 41.
5. Mohapatra S, Jha CB. Physicochemical characterization of Ayurvedic bhasma (Swarna makshika bhasma): an approach to standardization. Int J Ayurveda Res 2010;1:82â€“6.
6. Arun S, Murty VS, Chandra TS. Standardization of metal-based herbal medicines. Am J Infect Dis 2009;5:193-9.
7. Wadekar MP, Rodeb CV, Bendale YN, Patil DKR, Prabhune AA. Preparation and characterization of a copper based Indian traditional drug: Tamra bhasma. J Pharm Biomed Anal 2005;39:951â€“5.
8. Nagarajan S, Pemiah B, Krishnan UM, Rajan KS, Krishnaswamy S, Sethuraman S. Physico-chemical characterization of lead-based Indian traditional medicine-naga bhasma. Int J Pharm Pharm Sci 2012;4:69-74.
9. Kanase A, Patil S, Thorat B. Curative effects of mandur bhasma on liver and kidney of albino rats after induction of acute hepatitis by CCl. Indian J Exp Biol 1997;35:754-64.
10. Devarshi P, Kanase A, Kanase R, Mane S, Patil S, Varute AT. Effect of mandur Bhasma on lipolytic activities of liver, kidney and adipose tissue of albino rat during CCl4 induced hepatic injury. J Biosci 1986;10:227-34.
11. Krishnamachary B, Rajendran N, Pemiah B, Krishnaswamy S, Krishnan UM, Sethuraman S, et al. Scientific validation of the different purification steps involved in the preparation of an Indian Ayurvedic medicine, Lauha bhasma. J Ethnopharmacol 2012;142:98-104.
12. The Ayurvedic Pharmacopoeia of India. Part I. Vol. I. Delhi: Department of Indian System of Medicine and Homoeopathy, Government of India; 2001.
13. Saywell LG, Cunningham BB. Determination of iron: colorimetric o-phenanthroline method. Ind Eng Chem Anal Ed 1937;9:67â€“9.
14. The Ayurvedic pharmacopoeia of India, part I. Vol. III. Ist edition. The government of India, Ministry of health and family welfare, Department of Indian system of medicine and homoeopathy. New Delhi; 2001. p. 233-40.
15. Umamaheshwari M, Asokkumar K, Rathidevi R, Sivashanmugam AT, Subhadradevi V, Ravi TK. Antiulcer and in vitro antioxidant activities of Jasminum grandiflorum L. J Ethnopharmacol 2007;110:464-70.
16. Achliya GS, Wadodkar SG, Dorle AK. Evaluation of the hepatoprotective effect of Amalkadi Ghrita against carbon tetrachloride-induced hepatic damage in rats. J Ethnopharmacol 2004;90:229-32.
17. Ladda PL, Magdum CS, Naikwade NS. Hepatoprotective activity of Vitex negundo linn. by paracetamol induced hepatotoxicity in rats. Int J Pharmacol Res 2011;1:1-9.
18. Singh SK, Gautam DNS, Kumar M, Rai SB. Synthesis, characterization and histopathological study of a lead-based Indian traditional drug: Naga Bhasma. Indian J Pharm Sci 2010;72:24-30.
19. Bhargava SC, Reddy KR, Sastry GV. Identifications studies of Lauha Bhasma by X-ray diffraction and X-ray fluorescence. Ayu 2012;33:143-5.
20. Morris MC, McMurdie HF, Evans EH, Paretzkin B, Parker HS, Panagiotopoulos NC. Standard X-ray diffraction powder patterns. National Bureau of Standards Monograph. Washington DC; 1981.
21. Girish C, Koner BC, Jayanthi S, Rao KR, Rajesh B, Pradhan SC. Hepatoprotective activity of six polyherbal formulations in paracetamol induced liver toxicity in mice Indian J Med Res 2009;129:569-78.